Trestle Founding Team Co-Authors Report Describing Proof of Concept For Use of 3D Bioprinted Human Kidney Organoids in High Content Drug Screening

Dec 23, 2018

Founding scientists of Trestle co-author report demonstrating proof-of-concept for automated production of human kidney organoids using a 3D bioprinter. This approach enables rapid generation of large numbers of kidney organoids for use in high content compound screening.

Higgins, J.W. et al. Bioprinted pluripotent stem cell-derived kidney organoids provide opportunities for high content screening. bioRxiv 505396 (2018).